[go: up one dir, main page]

DK1663168T3 - Nikotinformuleringer og anvendelse deraf - Google Patents

Nikotinformuleringer og anvendelse deraf

Info

Publication number
DK1663168T3
DK1663168T3 DK04769203T DK04769203T DK1663168T3 DK 1663168 T3 DK1663168 T3 DK 1663168T3 DK 04769203 T DK04769203 T DK 04769203T DK 04769203 T DK04769203 T DK 04769203T DK 1663168 T3 DK1663168 T3 DK 1663168T3
Authority
DK
Denmark
Prior art keywords
nicotine
nicotine formulations
cellulose
formulations
algae
Prior art date
Application number
DK04769203T
Other languages
Danish (da)
English (en)
Inventor
Bo Ragnar Ek
Sven-Boerje Andersson
Bengt Ake Bosson
Nils-Olof Lindberg
Albert Mihranyan
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34277854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1663168(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0302387A external-priority patent/SE0302387D0/xx
Application filed by Mcneil Ab filed Critical Mcneil Ab
Application granted granted Critical
Publication of DK1663168T3 publication Critical patent/DK1663168T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK04769203T 2003-09-08 2004-08-27 Nikotinformuleringer og anvendelse deraf DK1663168T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50106103P 2003-09-08 2003-09-08
SE0302387A SE0302387D0 (sv) 2003-09-08 2003-09-08 Nicotine formulations and use thereof
PCT/IB2004/002787 WO2005023227A2 (fr) 2003-09-08 2004-08-27 Formulations de nicotine et leurs utilisations

Publications (1)

Publication Number Publication Date
DK1663168T3 true DK1663168T3 (da) 2009-06-08

Family

ID=34277854

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04769203T DK1663168T3 (da) 2003-09-08 2004-08-27 Nikotinformuleringer og anvendelse deraf

Country Status (13)

Country Link
US (1) US20050053665A1 (fr)
EP (1) EP1663168B1 (fr)
JP (1) JP4604034B2 (fr)
AT (1) ATE422355T1 (fr)
AU (1) AU2004269986A1 (fr)
BR (1) BRPI0414196A (fr)
CA (1) CA2537488A1 (fr)
DE (1) DE602004019430D1 (fr)
DK (1) DK1663168T3 (fr)
ES (1) ES2321721T3 (fr)
MX (1) MXPA06002609A (fr)
PL (1) PL1663168T3 (fr)
WO (1) WO2005023227A2 (fr)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383296A1 (fr) * 2002-05-10 2003-11-10 Ginette Godbout Composition pour l'amelioration de la sante et de la structure des ongles, methode d'utilisation
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
CA2514325C (fr) 2003-01-24 2013-11-12 Magle Holding Ab Matiere de composition pour administration a travers la muqueuse
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
DE10356925B4 (de) * 2003-12-05 2006-05-11 Lts Lohmann Therapie-Systeme Ag Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US20060240084A1 (en) * 2005-04-20 2006-10-26 Xylos Corporation Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use
JP5255449B2 (ja) * 2005-12-06 2013-08-07 エフ エム シー コーポレーション セルロースゲル配合物
JP5694645B2 (ja) * 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
CA2657932A1 (fr) * 2006-03-16 2007-09-20 Niconovum Ab Compositions de pastilles stables a liberation rapide de nicotine
CA2963423C (fr) * 2007-03-30 2020-07-28 Philip Morris Products S.A. Dispositif et procede pour administrer un medicament
EP2322167A1 (fr) * 2007-04-02 2011-05-18 Parkinson's Institute Procédés et compositions pour la réduction des effets indésirables de traitements thérapeutiques
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
WO2009037319A2 (fr) * 2007-09-18 2009-03-26 Niconovum Ab Compositions de chewing-gum stables comprenant du maltitol et assurant une libération rapide de nicotine
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
EP2230934B8 (fr) 2007-12-14 2012-10-24 AeroDesigns, Inc Administration de produits alimentaires sous forme d'aérosols
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
AR071850A1 (es) * 2008-05-21 2010-07-21 Novartis Ag Gomas de mascar en forma de tableta
WO2009148442A1 (fr) 2008-06-04 2009-12-10 Colgate-Palmolive Company Instrument de soin buccal avec système de cavitation
US20100018541A1 (en) * 2008-07-28 2010-01-28 Anthony Richard Gerardi Smokeless tobacco products and processes
EP2343995B1 (fr) * 2008-07-28 2012-08-29 R.J.Reynolds Tobacco Company Produits du tabac sans fumée et procédés
WO2010031552A1 (fr) * 2008-09-17 2010-03-25 Niconovum Ab Procédé de préparation d'une composition de tabac à priser
US8506936B2 (en) * 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
WO2010104464A1 (fr) 2009-03-13 2010-09-16 Excellens Tech. Products Aps Produit pour administration orale
PL2408494T3 (pl) 2009-03-17 2021-11-02 Philip Morris Products S.A. Układ do wytwarzania aerozolu na bazie tytoniu
US8551235B2 (en) 2009-04-23 2013-10-08 Green Wave Innovative Solutions, Llc Algae based fire resistant materials and method of making same
AU2010238945B2 (en) * 2009-04-24 2013-10-24 Omya International Ag Particulate material for controlled release of active ingredients
EP2477607B1 (fr) * 2009-09-16 2020-08-05 Philip Morris Products S.a.s. Dispositif et méthodes perfectionnés pour la distribution d'un médicament
WO2011101860A1 (fr) * 2010-02-18 2011-08-25 Jatin Vasant Thakkar Pastilles de gélatine molles contenant de la nicotine
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
SE535587C2 (sv) * 2011-03-29 2012-10-02 Chill Of Sweden Ab Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
EP2729148A4 (fr) 2011-07-06 2015-04-22 Parkinson S Inst Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
CA3208137A1 (fr) 2013-05-06 2014-11-13 Juul Labs, Inc. Formulations de sel de nicotine pour des dispositifs de generation d'aerosol et methodes connexes
ES2759227T3 (es) 2013-07-19 2020-05-08 Altria Client Services Llc Métodos y sistemas para incorporar nicotina en productos orales
US11503853B2 (en) * 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US12274276B2 (en) 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
AU2014357622B2 (en) * 2013-12-05 2019-10-24 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
CN113754634A (zh) 2014-05-27 2021-12-07 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体络合物
GB201411526D0 (en) * 2014-06-27 2014-08-13 British American Tobacco Co Powder
CA2974324A1 (fr) 2015-01-28 2016-08-04 Zita S. Netzel Procedes et systemes d'administration de medicament
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
GB201602579D0 (en) * 2016-02-12 2016-03-30 Mihranyan Albert New compositions
BR122023020807A2 (pt) 2016-04-12 2023-12-12 Arturo Solis Herrera Uso de agonistas do receptor de acetilcolina nicotínica no tratamento de uma condição de uma membrana mucosa nasal ou paranasal
CN114868950A (zh) 2016-12-30 2022-08-09 菲利普莫里斯生产公司 含有尼古丁的薄片
CA3049529A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
GB201714412D0 (en) * 2017-09-07 2017-10-25 Emplicure Ab Evaporation devices containing plant material
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
EP3807260B1 (fr) * 2018-06-15 2024-09-18 R. J. Reynolds Tobacco Company Purification de nicotine
WO2020002689A1 (fr) * 2018-06-28 2020-01-02 Philip Morris Products S.A. Cartouche pour un système de génération d'aérosol contenant une source de nicotine comprenant une formulation liquide de nicotine
US11432581B2 (en) * 2018-09-07 2022-09-06 Altria Client Services Llc Capsule containing a matrix, device with the matrix, and method of forming the matrix
US11395507B2 (en) 2018-09-07 2022-07-26 Altria Client Services Llc Filter for an e-vaping device, e-vaping device with the filter, and method of forming the filter
US11311048B2 (en) 2018-09-07 2022-04-26 Altria Client Services Llc E-vaping device with an insert
EP3880175A4 (fr) 2018-11-16 2022-08-17 Morningside Venture Investments Limited Système d'administration transdermique de médicaments à régulation thermique
DK180339B1 (en) * 2019-06-07 2020-12-18 Ncp Nextgen As Nicotine pouch composition and pouch comprising such
AU2020287198C1 (en) 2019-06-07 2025-09-11 Philip Morris Products S.A. Nicotine pouch composition and pouch comprising such
FI3833315T3 (sv) * 2019-10-04 2022-12-15 En påseprodukt lämplig för applicering i munhålan
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
US12161755B2 (en) 2020-11-14 2024-12-10 Regents Of The University Of Minnesota Sustained release device for treatment of Parkinson's disease and other disorders
EP4014759A1 (fr) 2020-12-18 2022-06-22 VIRAofSWEDEN AB Nouveau produit comprenant un extrait d'alga brun
EP4094594A1 (fr) 2021-05-25 2022-11-30 Consumer Brands International s.r.o. Remplissage d'une formulation de nicotine, en particulier un sachet de nicotine et son procédé de fabrication et mélange de sels de nicotine et son procédé de fabrication
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
WO2023187225A1 (fr) 2022-04-01 2023-10-05 Amplicon Ab Produits intra-buccaux alcalins

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US59939A (en) * 1866-11-27 Chakles e
US2002218A (en) * 1934-08-22 1935-05-21 Bell Telephone Labor Inc Tie trunk line
DE1517264C3 (de) * 1963-10-31 1978-09-07 Celanese Corp., New York, N.Y. (V.St.A.) Tabakfreies Tabakaustauschmaterial
GB1362611A (en) * 1972-03-14 1974-08-07 Ici Ltd Smoking mixtures
US4748181A (en) * 1979-08-28 1988-05-31 Foundation For Behavioral Research Method for treating hypertension with nicotine
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
WO1986001692A1 (fr) * 1984-09-09 1986-03-27 Akiko Kondo Filtre de tabac
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6024097A (en) * 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
JP3687194B2 (ja) * 1996-06-06 2005-08-24 味の素株式会社 水不溶性グルカンの精製方法
CA2319140A1 (fr) * 1998-02-06 1999-08-12 Monsanto Company Compositions cellulosiques acido-resistantes et compatibles avec des composants cationiques, et procedes de preparation associes
US6583160B2 (en) * 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
ES2708552T3 (es) * 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
CA2514325C (fr) * 2003-01-24 2013-11-12 Magle Holding Ab Matiere de composition pour administration a travers la muqueuse

Also Published As

Publication number Publication date
WO2005023227A3 (fr) 2005-06-16
ATE422355T1 (de) 2009-02-15
WO2005023227A2 (fr) 2005-03-17
DE602004019430D1 (de) 2009-03-26
EP1663168B1 (fr) 2009-02-11
JP2007505037A (ja) 2007-03-08
PL1663168T3 (pl) 2009-07-31
MXPA06002609A (es) 2006-06-05
BRPI0414196A (pt) 2006-10-31
EP1663168A2 (fr) 2006-06-07
ES2321721T3 (es) 2009-06-10
AU2004269986A1 (en) 2005-03-17
CA2537488A1 (fr) 2005-03-17
US20050053665A1 (en) 2005-03-10
JP4604034B2 (ja) 2010-12-22

Similar Documents

Publication Publication Date Title
DK1663168T3 (da) Nikotinformuleringer og anvendelse deraf
WO2006086562A3 (fr) Derives de phenylazetidinone
DE60327438D1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
CY1107399T1 (el) Μορφη χορηγησης απο του στοματος περιεχουσα προβιοτικα βακτηριδια
EP1780202A4 (fr) Derive de quinoline et insecticide contenant cellui-ci comme constituant actif
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
EA200870019A1 (ru) Лактамовые соединения и способы их применения
ATE509917T1 (de) Gamma-secretase-inhibitoren
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
NO20055722D0 (no) Antiseptiske preparater, fremgangsmater og systemer
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
WO2008039829A3 (fr) Inhibiteurs de l'absorption de cholestérol de diphénylhétérocycle
GB0121490D0 (en) Ciompounds
WO2008064345A3 (fr) Composés destructeurs de microorganismes
WO2005018605A3 (fr) Nouvelle formulation
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
ECSP088510A (es) Combinación fungicida de principios activos
TW200509794A (en) Novel anthelmintic and insecticidal compositions
MX2007005475A (es) Metabolitos de ciertos derivados de [1,4] diazepino [6,7,1-ij] quinolina y metodos de preparacion y uso de los mismos.
NO20063619L (no) Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
WO2003024996A3 (fr) Macrocycles antibacteriens
ATE509018T1 (de) Als antimikrobielle mittel geeignete bisindolpyrrole
WO2004108744A3 (fr) Azalides et azaketolides possedant une activite antimicrobienne
WO2004019865A3 (fr) Amelioration des effets de la fumee de cigarette